GRP
CRNX icon

Global Retirement Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Global Retirement Partners’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$358 Sell
7
-55
-89% -$3.08K ﹤0.01% 3451
2024
Q3 		$3.17K Sell
62
-197
-76% -$10.2K ﹤0.01% 2765
2024
Q2 		$11.6K Buy
+259
New +$12K ﹤0.01% 2249

Other funds holding CRNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Global Retirement Partners's CRNX Position: Q4 2024 in Review

Global Retirement Partners reduced its Crinetics Pharmaceuticals (CRNX) stake by 89% in Q4 2024, selling an estimated $3.08K and leaving 7 shares worth $358. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Global Retirement Partners first reported a position in CRNX in Q2 2024 and has held it in 3 quarters since. The position peaked at $11.6K in Q2 2024. 247 funds tracked by Wall St. Rank hold CRNX as of Q4 2024.

  • Global Retirement Partners held 7 shares of Crinetics Pharmaceuticals worth $358 as of Q4 2024.
  • Global Retirement Partners sold 55 Crinetics Pharmaceuticals shares in Q4 2024, an estimated $3.08K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #3451 holding.
  • Global Retirement Partners first reported a position in Crinetics Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • Global Retirement Partners's Crinetics Pharmaceuticals position peaked at $11.6K in Q2 2024.
  • 247 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.